Predictions
Abbott Laboratories
Start price
Target price
Perf. (%)
€62.80
23.03.20
23.03.20
€70.00
23.03.20
23.03.20
-5.86%
23.03.20
23.03.20
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€70.00
21.03.20
21.03.20
-
04.04.20
04.04.20
3.16%
04.04.20
04.04.20
Known brand
Fair valuation
Leading role in innovation
Future proof or reliable business model
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€76.81
19.03.20
19.03.20
€85.00
19.03.20
19.03.20
-3.91%
19.03.20
19.03.20
Known brand
Fair valuation
Leading role in innovation
Future proof or reliable business model
Meta Platforms Inc.
Start price
Target price
Perf. (%)
€136.90
19.03.20
19.03.20
€268.00
04.11.21
04.11.21
52.56%
18.01.21
18.01.21
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€126.32
18.03.20
18.03.20
€150.00
12.10.20
12.10.20
6.54%
12.10.20
12.10.20
Top 10 in its market
Could be worthwhile Investment >10% per year
High dividend yield expected
Innovative
Delta Air Lines Inc.
Start price
Target price
Perf. (%)
€27.78
18.03.20
18.03.20
€20.00
04.11.21
04.11.21
38.80%
26.05.21
26.05.21
Pfizer Inc.
Start price
Target price
Perf. (%)
€27.04
17.03.20
17.03.20
€33.21
04.11.21
04.11.21
47.75%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Oracle Corp.
Start price
Target price
Perf. (%)
€37.64
13.03.20
13.03.20
€50.00
18.03.20
18.03.20
10.53%
18.03.20
18.03.20
Future proof or reliable business model
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Alexion Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€70.50
12.03.20
12.03.20
€145.00
04.11.21
04.11.21
119.55%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Johnson & Johnson
Start price
Target price
Perf. (%)
€117.78
11.03.20
11.03.20
€150.00
04.11.21
04.11.21
20.58%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Amazon.com Inc.
Start price
Target price
Perf. (%)
€84.11
06.03.20
06.03.20
€125.00
21.04.20
21.04.20
24.93%
21.04.20
21.04.20
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
High valuation
Apple Inc.
Start price
Target price
Perf. (%)
€63.75
06.03.20
06.03.20
€112.50
28.08.20
28.08.20
65.43%
28.08.20
28.08.20
positive Cash Flow expected
Good rating
Standard Investments for future growth
Valuable balance sheet
Tiffany & Co.
Start price
Target price
Perf. (%)
€123.32
21.02.20
21.02.20
€130.00
04.11.21
04.11.21
-11.72%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Market Leader or Top 3
Small cyclical dependencies
Well known brand
Alphabet Inc. C
Start price
Target price
Perf. (%)
€69.69
12.02.20
12.02.20
€0.11
04.11.21
04.11.21
84.75%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Berkshire Hathaway Inc. B
Start price
Target price
Perf. (%)
€208.10
07.02.20
07.02.20
€250.00
04.11.21
04.11.21
19.97%
05.11.21
05.11.21